UNSPSC 51372208: Dextropropoxyphene hydrochloride

This classification denotes an opioid receptor agonist and opioid with the molecular formula C22H29NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CB2TL9PS0T, chemically known as 2-butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate (ester), hydrochloride, (+)- but more generally known as dextropropoxyphene hydrochloride, which bears US NIH Compound Identifier 15424.

European Medicines Agency schedules Dextropropoxyphene hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01649MIG. Most nations, for tariff and trade purposes, schedule dextropropoxyphene hydrochloride under HS 29221400. SMILES: CCC(=O)O[C@](CC1CCCCC1)(C2CCCCC2)[C@H](C)CN(C)C.CL.

UNSPSC 51372208 Dextropropoxyphene hydrochloride is a Commodity code that state and local governments use to classify pharmaceutical procurement, though the recent activity under this code shows minimal alignment with the nominal product — the one recent solicitation actually targets naloxone and drug deactivation systems rather than dextropropoxyphene itself. State and local procurement offices tag pharmaceutical and medical-supply purchases under this and related commodity codes, but the scope of work varies widely depending on the health or safety mission of the issuing body. The issuing bodies under this code include county health departments and public health agencies procuring on behalf of community health initiatives, particularly those focused on opioid response and harm reduction.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023, at 2:00 pm. The contract carries a two-year initial term with an optional one-year renewal, requires vendors to include all shipping and delivery costs in their bids, and mandates E-Verify compliance, drug-free workplace certification, and standard insurance coverage including workers' compensation and commercial general liability. The procurement may be FEMA-funded, introducing federal compliance requirements. Beyond this single recent opportunity, the source shows little other state and local activity under this specific code, suggesting either light recent procurement volume or systematic miscoding of pharmaceutical purchases across the state and local market.